Skip to main content

Published locations for Rucaparib – second PARP inhibitor hits the market for ovarian cancer

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Rucaparib – second PARP inhibitor hits the market for ovarian cancer

User login

  • Reset your password
  • /content/rucaparib-second-parp-inhibitor-hits-market-ovarian-cancer-0
  • /jcso/article/137074/gynecologic-cancer/rucaparib-second-parp-inhibitor-hits-market-ovarian-cancer
  • /hematology-oncology/article/137074/gynecologic-cancer/rucaparib-second-parp-inhibitor-hits-market